CBMG Holdings Completes $120 Million in Series A Funding, Accelerating Development of CAR-T Therapy Pipelines and R&D for Innovative Solid Tumor Therapies
- Thursday, September 30, 2021, 7:42
- PR Newswire
- Add a comment
HONG KONG, Sept. 30, 2021 /PRNewswire/ — CBMG Holdings (or the “Company”), a Cayman Island biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer and degenerative diseases, today announced the closing of a $120 million Series A investment,…
About the Author
admin has written 20022 stories on this site.